David Kroin Net Worth & Insider Trades

David Kroin Adamas Pharmaceuticals Inc

As of June 21, 2017

What is David Kroin's Net Worth?

The current estimated net worth of Adamas Pharmaceuticals Inc's David Kroin is estimated to be about $61.02M . David Kroin owns about 2,216,351 units of Adamas Pharmaceuticals Inc common stock. Recently at Adamas Pharmaceuticals Inc, David Kroin has sold an estimated value of $6.49M worth.

What is David Kroin's Past Insider Trading?

David Kroin's largest sale order was 380,000 units , worth over $6.49M on June 21, 2017. In total, David Kroin has made about 1 transaction recently at Adamas Pharmaceuticals Inc. David Kroin usually trades in June, with the busiest year in 2017.

GREAT POINT PARTNERS LLC, JEFFREY JAY, DAVID KROIN

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is David Kroin's' Mailing Address?

  • Mailing address is C/o Great Point Partners Llc 165 Mason Street, 3rd Floor Greenwich CT 06830 CT

Adamas Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Stock Awards
Option Awards
Other Compensation
Total
Neil F. McFarlane 2020 $604,167 $31,300 $431,300 $199,000 $233,220 $193,954 $1,692,941
Neil F. McFarlane 2019 $182,292 - $125,200 $781,250 $957,325 $34,575 $2,080,642
Vijay Shreedhar, Ph.D. 2020 $418,034 $21,700 $224,600 $55,100 $64,367 $58,498 $842,299
Vijay Shreedhar, Ph.D. 2019 $252,344 - $130,200 $321,063 $397,513 $128,974 $1,230,094
Christopher B. Prentiss 2020 $386,667 $20,000 $184,000 $23,200 - $6,912 $620,779
Christopher B. Prentiss 2019 $358,333 - $184,000 $245,188 $298,980 $7,140 $1,093,641
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1328143/000132814321000033/adms2021proxystatement.htm

What are Adamas Pharmaceuticals Inc's Past Insider Trades?

Adamas Pharmaceuticals Inc's most recent insider trade came on June 23, 2021 by Vijay Shreedhar who sold 6,200 units worth $31.98K . In the last 7 years, insiders at Adamas Pharmaceuticals Inc have sold an estimated value of $27.45M and bought an estimated value of $19.72M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are William Ericson, Director,  Gregory Went, Chief Executive Officer,  and Ivan Lieberburg, Director .

Adamas Pharmaceuticals Inc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1